Search for: "Eli Lilly "
Results 881 - 900
of 2,131
Sorted by Relevance
|
Sort by Date
22 Dec 2009, 2:42 pm
According to Dr Reddy's, the patent was a pretty sick one since it suffered from (i) an acute deficiency of novelty over a prior disclosure made by Eli Lilly in an earlier patent; (ii) glaring obviousnessness over the same patent and (iii) a further bout of obviousness which had been brought about by the earlier publication of an article by one of Eli Lilly's scientists. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) - Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) - US: Watson and Barr settle patent litigation (SmartBrief)… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent… [read post]
19 Oct 2010, 12:20 pm
Eli Lilly & Co., 2010 WL 4024922 (D.S.D. [read post]
20 Jun 2011, 7:01 pm
Court of Appeals for the Federal Circuit in Eli Lilly & Co. v. [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP… [read post]
25 Apr 2016, 3:01 pm
The complaint alleges that Eli Lilly and Elan infringe U.S. [read post]
27 Jul 2008, 4:07 pm
Eli Lilly & Co., No. 07-cv-1749 (MDL-1596 E.D.N.Y.). [read post]
7 Jan 2018, 12:47 pm
While the Federal Patent Court denied infringement of Eli Lilly’s patent by Actavis’ generic version comprised of pemetrexed diacid because of the limitation introduced by the patentee during examination proceedings, the Supreme Court disagreed and granted Eli Lilly’s appeal against the decision of the Federal Patent Court. [read post]
12 Jun 2023, 10:30 pm
Pharmaceutical company, Eli Lilly, settled with insulin buyers after six years of litigation, plaintiffs having alleged civil conspiracy for high-priced insulin, Eli Lilly agreeing to pay $13.5 million and continue to apply a $35/month cap on users’ out-of-pocket costs for four years. [read post]
12 Jul 2018, 2:15 am
EPLaw reports on the recent decision by the Danish High Court that selection of the dosage regime would not have been obvious: DK - Eli Lilly v Sandoz/The Danish Maritime and Commercial High Court (Tadalafil). [read post]
3 Aug 2018, 8:22 am
Highlights this week include a one-year-on perspective of Actavis v Eli Lilly, further news on the progress of the DSM Directive and an update on the governance issues of the Collecting Society of Nigeria (COSON).PatentsThe Kluwer Patent Blog marks the first year anniversary of the landmark Supreme Court decision Actavis v Eli Lilly: Actavis and Equivalents – One Year On. [read post]
13 May 2013, 7:34 am
Eli Lilly applied for the patent and then Novapharm sought to bring a generic version of olanzapine to market. [read post]
14 Feb 2019, 3:03 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
9 Mar 2018, 1:00 am
Recent cases such as Trunki and Actavis v Eli Lilly in the Supreme Court and the CJEU ruling in Specsavers have drawn into focus the relationship between the representation contained on the patent, trade mark and design registers and the scope of protection conferred by those registrations. [read post]
27 Aug 2010, 9:54 pm
Eli Lilly; • Drafting of Second Medical Use Claims after G2/08: How to ensure that a patent is likely to be valid; • The current state of play for biosimilars in the U.S. and in Europe: Where do... [read post]
14 Nov 2008, 5:54 am
In the paper, entitled "The Changing Legal Landscape For Intellectual Property," former Attorney General and Pennsylvania Governor Dick Thornburgh (Of Counsel at K&L Gates LLP), moderates a discussion on the role that intellectual property protection plays in commerce and innovation with Robert Armitage, Senior Vice President and General Counsel of Eli Lilly and Company; Michael Fricklas, Executive Vice President, General Counsel,... [read post]
9 Sep 2008, 6:28 am
Eli Lilly", with Gentry Gallery v. [read post]
4 Dec 2009, 3:01 pm
Panelists for the discussion include Hal Wegner of Foley and Lardner LLP; Larry Welch, the Assistant General Patent Counsel at Eli Lilly and... [read post]
6 Aug 2022, 7:34 pm
And in Sunday’s edition of The New York Times, Lora Kelley will have an article headlined “Major Indiana Employers Criticize State’s New Abortion Law; The drug company Eli Lilly said it ‘will be forced’ to look outside the state for employment growth; The engine maker Cummins said the law will ‘impede our ability to attract and retain top talent. [read post]
